Cargando…
Topical Omega-3 Polyunsaturated Fatty Acids for the Treatment of Dry Eye – Results from a Pilot Randomized Controlled Masked-Observer Study
PURPOSE: To investigate the efficacy, safety and tolerability of topical omega-3 polyunsaturated fatty acids (PUFA) as an innovative treatment of dry eye disease (DED). PATIENTS AND METHODS: In a pilot, multicenter, masked-observer, randomized, active-controlled, non-inferiority study in Germany, pa...
Autores principales: | Kaercher, Thomas, Messmer, Elisabeth M, Berninger, Thomas, Huber-van der Velden, Klaudia K, Geiger, Raphaela, Cipriano-Bonvin, Pauline, Jacobi, Christina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744874/ https://www.ncbi.nlm.nih.gov/pubmed/36523849 http://dx.doi.org/10.2147/OPTH.S388294 |
Ejemplares similares
-
A Water-Free Omega-3 Fatty Acid Eye Drop Formulation for the Treatment of Evaporative Dry Eye Disease: A Prospective, Multicenter Noninterventional Study
por: Jacobi, Christina, et al.
Publicado: (2022) -
Finger-Prick Autologous Blood (FAB) Eye Drops for Dry Eye Disease: Single Masked Multi-Centre Randomised Controlled Trial
por: Hassan, Ali, et al.
Publicado: (2022) -
Dietary Intervention With a Targeted Micronutrient Formulation Reduces the Visual Discomfort Associated With Vitreous Degeneration
por: Ankamah, Emmanuel, et al.
Publicado: (2021) -
A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease
por: Taylor, Mike, et al.
Publicado: (2019) -
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease
por: Steven, Philipp, et al.
Publicado: (2017)